Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions.

NCT00694317 is registered in ClinicalTrials.gov with Roxane Laboratories as lead sponsor.

NCT NCT00694317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00694317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions.
Lead sponsor
Roxane Laboratories
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2004
Completion date
February 29, 2004
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

short term treatment of insomnia